[1]
Y. Gurzhenko, “Study of the Efficiency of Using Type 5 Phosphodiesterase Inhibitors in the Therapy of Ereсtile Dysfunction in Patients with Metabolic Syndrome”, HM, no. 3, pp. 58–69, Sep. 2021.